Effects of 5-HT3 receptor agonists on voluntary ethanol intake in rats maintained on a limited access procedure

被引:0
作者
Dyr, W [1 ]
Kostowski, W [1 ]
机构
[1] INST PSYCHIAT & NEUROL,DEPT PHARMACOL & PHYSIOL NERVOUS SYST,PL-02957 WARSAW,POLAND
来源
ALCOHOL AND ALCOHOLISM | 1997年 / 32卷 / 04期
关键词
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Recent evidence from a variety of laboratory studies suggests that the central effects of ethanol (EtOH) are mediated by serotonin 5-HT3 receptors. Notably, EtOH is able to potentiate 5-HT action on 5-HT3 ionophore, and 5-HT3 antagonists are known to reduce certain effects of EtOH. In the present study, we evaluated the effects of two agonists of 5-HT3 receptors, 2-methyl-5-HT (2-Me-5-HT) and m-chlorophenylbiguanide (m-CPBG) that were microinjected i.c.v. and into the nucleus accumbens (NAC) on EtOH intake in Wistar rats with high EtOH preference. 2-Me-5-HT given i.c.v. (1 and 10 mu g per rat) and into the NAC (bilaterally 1 and 10 mu g per site) significantly reduced EtOH intake in the limited access paradigm (2h session). On the other hand m-CPBG was inactive after intra-NAC administration It is concluded that central 5-HT3 receptors are involved in the regulation of EtOH consumption.
引用
收藏
页码:455 / 462
页数:8
相关论文
共 50 条
  • [1] ASHBY CR, 1991, BRAIN RES, V550, P191
  • [2] BEHAVIORAL PHARMACOLOGY OF 5-HT3-RECEPTOR LIGANDS
    BARNES, JM
    BARNES, NM
    COOPER, SJ
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1992, 16 (01) : 107 - 113
  • [3] CHARACTERIZATION AND AUTORADIOGRAPHIC LOCALIZATION OF 5-HT3 RECEPTOR RECOGNITION SITES IDENTIFIED WITH [3H]-(S)-ZACOPRIDE IN THE FOREBRAIN OF THE RAT
    BARNES, JM
    BARNES, NM
    CHAMPANERIA, S
    COSTALL, B
    NAYLOR, RJ
    [J]. NEUROPHARMACOLOGY, 1990, 29 (11) : 1037 - &
  • [4] BLANDINA P, 1989, J PHARMACOL EXP THER, V251, P803
  • [5] PHARMACOLOGICAL CHARACTERIZATION OF 5-HYDROXYTRYPTAMINE(3) RECEPTORS IN MURINE BRAIN AND ILEUM USING THE NOVEL RADIOLIGAND [H-3] RS-42358-197 - EVIDENCE FOR RECEPTOR HETEROGENEITY
    BONHAUS, DW
    WONG, EHF
    STEFANICH, E
    KUNYSZ, EA
    EGLEN, RM
    [J]. JOURNAL OF NEUROCHEMISTRY, 1993, 61 (05) : 1927 - 1932
  • [6] THE 5-HT3, RECEPTOR AGONIST 1-(M-CHLOROPHENYL)-BIGUANIDE INTERACTS WITH THE DOPAMINE TRANSPORTER IN RAT-BRAIN SYNAPTOSOMES
    CAMPBELL, AD
    WOMER, DE
    SIMON, JR
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 290 (02): : 157 - 162
  • [7] 5-HT3 RECEPTOR ANTAGONISTS BLOCK MORPHINE-INDUCED AND NICOTINE-INDUCED PLACE-PREFERENCE CONDITIONING
    CARBONI, E
    ACQUAS, E
    LEONE, P
    PEREZZANI, L
    DICHIARA, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 151 (01) : 159 - 160
  • [8] DIFFERENTIAL INHIBITORY EFFECTS OF A 5-HT3 ANTAGONIST ON DRUG-INDUCED STIMULATION OF DOPAMINE RELEASE
    CARBONI, E
    ACQUAS, E
    FRAU, R
    DICHIARA, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 164 (03) : 515 - 519
  • [9] ACTIVATION OF 5-HT3 RECEPTOR BY 1-PHENYLBIGUANIDE INCREASES DOPAMINE RELEASE IN THE RAT NUCLEUS-ACCUMBENS
    CHEN, J
    VANPRAAG, HM
    GARDNER, EL
    [J]. BRAIN RESEARCH, 1991, 543 (02) : 354 - 357
  • [10] EFFECTS OF THE 5-HT3 RECEPTOR ANTAGONIST, GR38032F, ON RAISED DOPAMINERGIC ACTIVITY IN THE MESOLIMBIC SYSTEM OF THE RAT AND MARMOSET BRAIN
    COSTALL, B
    DOMENEY, AM
    NAYLOR, RJ
    TYERS, MB
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (04) : 881 - 894